SPOP–PTEN–SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway

被引:0
|
作者
Bo’ang Han
Zhen Sun
Tingting Yu
Yu Wang
Lun Kuang
Tianyuan Li
Jing Cai
Qing Cao
Yuan Xu
Binbin Gao
Steven Y. Cheng
Shen Yue
Chen Liu
机构
[1] Nanjing Medical University,Department of Medical Genetics
[2] Nanjing Medical University,Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine
[3] Nanjing Medical University,Jiangsu Key Laboratory of Xenotransplantation
[4] Affiliated Zhongshan Hospital of Dalian University,Department of Pathology
[5] Henan University of Science and Technology,College of Medicine
[6] Nanjing Medical University,The First School of Clinical Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although E3 ligase Speckle type BTB/POZ protein (SPOP) promotes tumorigenesis by acting as a key regulatory hub in clear cell renal cell carcinoma (ccRCC), the detailed molecular mechanism remains unclear. Here, we demonstrate that a well-known tumor suppressor, Suppressor of Fused (SUFU), is downregulated by SPOP. Interestingly, this downregulation depends on cullin-3(Cul3)-SPOP E3 ligase, but SUFU is not a direct substrate of SPOP. Phosphatase and tensin homolog (PTEN), a ubiquitinated substrate of SPOP, is involved in SPOP-mediated SUFU reduction. Importantly, inhibition of SUFU leads to elevated SHH and WNT signaling, consequently rescuing the reduced proliferation, migration, and invasion abilities of ccRCC cells caused by SPOP-knockdown. Moreover, combinatorial treatment with SHH and WNT inhibitors shows more effective for suppressing ccRCC cell proliferation and aggressiveness. These findings demonstrate that a novel SPOP–PTEN–SUFU axis promotes ccRCC carcinogenesis by activating SHH and WNT pathway, providing a new treatment strategy for ccRCC.
引用
收藏
相关论文
共 50 条
  • [41] MSRB3 promotes the progression of clear cell renal cell carcinoma via regulating endoplasmic reticulum stress
    Ye, Xuxiao
    Liang, Tao
    Deng, Chao
    Li, Zuowei
    Yan, Dongliang
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [42] FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway
    Haixiang Shen
    Yufan Ying
    Xueyou Ma
    Haiyun Xie
    Shiming Chen
    Jiazhu Sun
    Zixiang Liu
    Chao Wen
    Zitong Yang
    Xiao Wang
    Mingjie Xu
    Jindan Luo
    Ben Liu
    Jiangfeng Li
    Xiangyi Zheng
    Liping Xie
    Cell Death Discovery, 8
  • [43] FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
    Liu, Jiachen
    Huang, Shiyu
    Hou, Yanguang
    Fu, Shujie
    Wang, Lei
    Hu, Juncheng
    Liu, Cheng
    Liu, Xiuheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression
    Bansal, Ankita
    Sanchez, Danielle J.
    Nimgaonkar, Vivek
    Sanchez, David
    Riscal, Romain
    Skuli, Nicolas
    Simon, M. Celeste
    MOLECULAR CANCER RESEARCH, 2019, 17 (09) : 1881 - 1892
  • [45] Epigenetic regulation of FOXI2 promotes clear cell renal cell carcinoma progression
    Zhou, Shuai
    Cheng, Cong
    Liao, Yi Xiang
    Wang, Li
    Zeng, Jin Min
    Zhou, Fang Fang
    Zhang, Xiu Qin
    Yang, Tao
    HELIYON, 2024, 10 (08)
  • [46] Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression
    Fan, Wen-Lang
    Yeh, Yuan-Ming
    Liu, Tsung-Ta
    Lin, Wei-Ming
    Yang, Tse-Yen
    Lee, Chao-Wei
    Lin, Tsung-Chieh
    BIOMOLECULES, 2021, 11 (03) : 1 - 15
  • [47] TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
    Pan, Qiufeng
    Cheng, Gong
    Liu, Yuenan
    Xu, Tianbo
    Zhang, Hao
    Li, Bing
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (05) : 1101 - 1114
  • [48] Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights
    Alves, Angela
    Medeiros, Rui
    Teixeira, Ana Luisa
    Dias, Francisca
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):
  • [49] Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis
    Zeng, Xing
    Hu, Zhiquan
    Ke, Xinwen
    Tang, Huake
    Wu, Bolin
    Wei, Xian
    Liu, Zheng
    CELL CYCLE, 2017, 16 (22) : 2212 - 2219
  • [50] LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway
    Zhu, L.
    Liu, X-L
    Fu, Z-Q
    Qiu, P.
    Feng, T.
    Yan, B.
    Wei, J-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2313 - 2320